Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05WXM
|
|||
Drug Name |
PMID27109571-Compound-18
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H19ClFN5
|
|||
Canonical SMILES |
CCC(CC)C1=NC2=CC(=C(C=C2C(=C1C3=NNN=N3)C4=CC=CC=C4)Cl)F
|
|||
InChI |
1S/C21H19ClFN5/c1-3-12(4-2)20-19(21-25-27-28-26-21)18(13-8-6-5-7-9-13)14-10-15(22)16(23)11-17(14)24-20/h5-12H,3-4H2,1-2H3,(H,25,26,27,28)
|
|||
InChIKey |
OTAAEQZYEFGHGG-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid-binding protein 4 (FABP4) | Target Info | Inhibitor | [1] |
Fatty acid-binding protein 5 (FABP5) | Target Info | Inhibitor | [1] | |
Target's Patent Info | Fatty acid-binding protein 4 (FABP4) | Target's Patent Info | [1] | |
Fatty acid-binding protein 5 (FABP5) | Target's Patent Info | [1] | ||
KEGG Pathway | PPAR signaling pathway | |||
NetPath Pathway | IL1 Signaling Pathway | |||
TCR Signaling Pathway | ||||
Pathway Interaction Database | AP-1 transcription factor network | |||
Reactome | Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |||
Transcriptional regulation of white adipocyte differentiation | ||||
WikiPathways | Lipid digestion, mobilization, and transport | |||
Transcriptional Regulation of White Adipocyte Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.